Modulation of Tyrosine Kinase Activity Has Multiple Actions on Insulin Release from the Pancreatic β : Cell: Studies with Lavendustin A

この論文にアクセスする

この論文をさがす

著者

抄録

We investigated the role of tyrosine kinases in the regulation of insulin release from a hamster β-cell line, HIT T15, using selective tyrosine kinase inhibitors. Genistein increased the insulin release induced by glucose, but herbimycin A, tyrphostins and the erbstatin analogue failed to change the release. Lavendustin A at 0.1 nM -1 μM caused a concave-shaped inhibition of the insulin release stimulated by 7 mM glucose. The inhibitory effect of lavendustin A was overcome by higher concentrations of glucose. Lavendustin B, the negative control analogue, had no effect on the release. Lavendustin A at a nanomolar range progressively inhibited insulin release by high K<SUP>+</SUP> (50 mM)-depolarization, whereas the inhibitor did not change the insulin release by Ca<SUP>2+</SUP> ionophore (A23187). On the contrary, lavendustin A at 10 nM significantly increased insulin release when glucose-induced insulin release was enhanced by either 5 μM forskolin or 162 nM 12-Ο-tetradecanoylphorbol 13-acetate. Lavendustin A failed to influence the Ca<SUP>2+</SUP>-induced insulin release from HIT cells permeabilized with streptolysin-Ο. These findings suggest that tyrosine kinases may play versatile roles in the control of insulin release from the pancreatic β-cell.

収録刊行物

  • The Japanese journal of pharmacology

    The Japanese journal of pharmacology 74(2), 203-208, 1997-06-01

    The Japanese Pharmacological Society

参考文献:  30件中 1-30件 を表示

各種コード

  • NII論文ID(NAID)
    10008679009
  • NII書誌ID(NCID)
    AA00691188
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    00215198
  • NDL 記事登録ID
    4260350
  • NDL 雑誌分類
    ZS51(科学技術--薬学)
  • NDL 請求記号
    Z53-D199
  • データ提供元
    CJP書誌  NDL  J-STAGE 
ページトップへ